Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TEV-56192 by Teva Pharmaceutical Industries for Unspecified Neurologic Disorders: Likelihood of Approval
TEV-56192 is under clinical development by Teva Pharmaceutical Industries and currently in Phase I for Unspecified Neurologic Disorders. According to...
Data Insights
TEV-56192 by Teva Pharmaceutical Industries for Unspecified Immunological Disorders: Likelihood of Approval
TEV-56192 is under clinical development by Teva Pharmaceutical Industries and currently in Phase I for Unspecified Immunological Disorders. According to...